Page last updated: 2024-08-26

fotemustine and Neutropenia

fotemustine has been researched along with Neutropenia in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	5 (83.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carapella, CM; Carosi, M; Cognetti, F; Fabi, A; Jandolo, B; Maschio, M; Metro, G; Mirri, MA; Pace, A; Russillo, M; Sperduti, I; Telera, S; Vidiri, A	1
Baruchel, S; Bouffet, E; Gammon, J; Grant, RM; Hargrave, DR; Tariq, N	1
Ardiet, C; Berger, E; Bouafia, F; Coiffier, B; Dumontet, C; Guyotat, D; Jaubert, J; Lucas, C; Sebban, C; Tranchand, B	1
Lee, SM; Margison, GP; Thatcher, N; Woodcock, AA	1
Ascierto, PA; Cellerino, R; Comella, G; Comella, P; Daponte, A; DeLena, M; Gravina, A; Marini, G; Melucci, MT; Palmieri, G	1
Bourg, V; Chichmanian, RM; Frenay, M; Lebrun, C; Thomas, P	1

Trials

4 trial(s) available for fotemustine and Neutropenia

Article	Year
Phase I study of fotemustine in pediatric patients with refractory brain tumors. Cancer, 2002, Sep-15, Volume: 95, Issue:6 Topics: Adolescent; Anemia; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Ependymoma; Female; Humans; Infant; Injections, Intravenous; Male; Medulloblastoma; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Sarcoma; Thrombocytopenia; Treatment Outcome	2002
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:4 Topics: Aged; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Outpatients; Prognosis; Recurrence; Sepsis; Thrombocytopenia	2003
Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma. British journal of cancer, 1993, Volume: 67, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Melanoma; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Respiratory Distress Syndrome; Thrombocytopenia	1993
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group. Cancer, 2000, Dec-15, Volume: 89, Issue:12 Topics: Adult; Aged; Anemia; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; CD146 Antigen; Cisplatin; Dacarbazine; Female; Fever; Follow-Up Studies; Humans; Interferon-alpha; Male; MART-1 Antigen; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Nausea; Neoplasm Proteins; Neural Cell Adhesion Molecules; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting	2000

Other Studies

2 other study(ies) available for fotemustine and Neutropenia

Article	Year
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation. BMC cancer, 2009, Mar-31, Volume: 9 Topics: Adult; Aged; Antineoplastic Agents; DNA Methylation; Dose-Response Relationship, Drug; Follow-Up Studies; Glioma; Humans; Karnofsky Performance Status; Middle Aged; Multivariate Analysis; Nausea; Neoplasm Recurrence, Local; Neutropenia; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Promoter Regions, Genetic; Retrospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting	2009
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:2 Topics: Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Interactions; Epilepsy; Etoposide; Female; Glioma; Hematologic Tests; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Thrombocytopenia; Valproic Acid	2001

Article

Year

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation.

BMC cancer, 2009, Mar-31, Volume: 9

Topics: Adult; Aged; Antineoplastic Agents; DNA Methylation; Dose-Response Relationship, Drug; Follow-Up Studies; Glioma; Humans; Karnofsky Performance Status; Middle Aged; Multivariate Analysis; Nausea; Neoplasm Recurrence, Local; Neutropenia; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Promoter Regions, Genetic; Retrospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting

2009

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity.

Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:2

Topics: Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Interactions; Epilepsy; Etoposide; Female; Glioma; Hematologic Tests; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Thrombocytopenia; Valproic Acid

2001